doi: 10.3390/ijms23147965 42 KohWKwakHCheongELeeCJ
Diabet Med 26:649654 Thondam SK, Cross A, Cuthbertson DJ, Wilding JP, Daousi C (2012) Effects of chronic treatment with metformin on dipeptidyl peptidase-4 activity, glucagon-like peptide 1 and ghrelin in obese patients with type 2 diabetes mellitus
In 2026 alone, the FDA has approved several new weight-loss medications, with even more options seemingly in the pipeline
Routine monitoring includes heart rate, blood pressure, renal function, and glycaemic control in accordance with NICE guidance
You may also need to stop eating or drinking for six to eight hours before your appointment